Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.
2.

Fine needle aspiration cytology of solid neuroendocrine carcinoma of the breast: a case report.

Kawanishi N, Norimatsu Y, Funakoshi M, Kamei T, Sonobe H, Kawano R, Kobayashi TK.

Diagn Cytopathol. 2011 Jul;39(7):527-30. doi: 10.1002/dc.21494. Epub 2010 Nov 2.

PMID:
21695806
3.

Neuroendocrine carcinomas of the breast.

Rovera F, Masciocchi P, Coglitore A, La Rosa S, Dionigi G, Marelli M, Boni L, Dionigi R.

Int J Surg. 2008;6 Suppl 1:S113-5. doi: 10.1016/j.ijsu.2008.12.007. Epub 2008 Dec 13.

4.

Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.

Righi L, Sapino A, MarchiĆ² C, Papotti M, Bussolati G.

Semin Diagn Pathol. 2010 Feb;27(1):69-76.

PMID:
20306832
5.

Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance.

Kawasaki T, Mochizuki K, Yamauchi H, Inoue S, Kondo T, Oishi N, Nakazawa T, Yamane T, Koshimizu Y, Tsunoda H, Yagata H, Inoue M, Inoue A, Maruyama T, Fujii H, Katoh R.

J Clin Pathol. 2012 Aug;65(8):699-703. doi: 10.1136/jclinpath-2012-200765. Epub 2012 May 3.

PMID:
22554967
6.

Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.

Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH.

Histopathology. 2004 Oct;45(4):343-51.

PMID:
15469472
7.

A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.

Okoshi K, Saiga T, Hisamori S, Iwaisako K, Kobayashi H, Ogawa H.

Breast Cancer. 2012 Oct;19(4):360-4. doi: 10.1007/s12282-009-0160-6. Epub 2009 Aug 11.

PMID:
19669861
8.

A case of multicentric low-grade neuroendocrine breast tumor with an unusual histological pattern.

D'Antonio A, Addesso M, Memoli D, Cascone A, Cremone L.

Breast Dis. 2016;36(4):161-164. doi: 10.3233/BD-160226.

PMID:
27802189
10.

Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.

Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G.

Mod Pathol. 2001 Aug;14(8):768-76.

11.

[Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].

Yang WT, Xu YX, Zhang TQ.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):594-7. Chinese.

PMID:
17134566
12.

Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.

Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D.

Hum Pathol. 2003 Oct;34(10):1001-8.

PMID:
14608533
14.

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.

Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G.

Cancer. 2003 May 15;97(10):2487-97.

15.

High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge.

Kawasaki T, Mochizuki K, Yamauchi H, Yagata H, Kondo T, Tsunoda H, Nakamura S, Oishi N, Nakazawa T, Yamane T, Inoue A, Maruyama T, Inoue M, Inoue S, Fujii H, Katoh R.

Breast. 2012 Oct;21(5):652-6. doi: 10.1016/j.breast.2012.01.016. Epub 2012 Mar 6.

PMID:
22397895
16.

Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.

Kawasaki T, Nakamura S, Sakamoto G, Murata S, Tsunoda-Shimizu H, Suzuki K, Takahashi O, Nakazawa T, Kondo T, Katoh R.

Histopathology. 2008 Sep;53(3):288-98. doi: 10.1111/j.1365-2559.2008.03093.x. Epub 2008 Jul 23.

PMID:
18657193
17.

Synchronous bilateral neuroendocrine ductal carcinoma in situ.

Honami H, Sotome K, Sakamoto G, Iri H, Tanaka Y, Fukamachi S, Morozumi K.

Breast Cancer. 2014 Jul;21(4):508-13. doi: 10.1007/s12282-011-0278-1. Epub 2011 Jul 7.

PMID:
21735237
18.

Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.

Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y.

Histopathology. 2011 Jul;59(1):106-15. doi: 10.1111/j.1365-2559.2011.03880.x. Epub 2011 Jun 13.

PMID:
21668471
19.

[Breast carcinoma with predominant neuroendocrine differentiation].

Frachon S, Pasquier D, Treilleux I, Seigneurin D, Ringeisen F, Rosier P, Bolla M, Boutonnat J.

Ann Pathol. 2004 Jun;24(3):278-83. Review. French.

PMID:
15480266
20.

Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?

Kawasaki T, Kondo T, Nakazawa T, Mochizuki K, Yamane T, Murata S, Inoue S, Tsunoda H, Katoh R.

Pathol Int. 2011 Jan;61(1):49-51. doi: 10.1111/j.1440-1827.2010.02604.x. No abstract available.

PMID:
21166944

Supplemental Content

Support Center